麻醉疼痛指南

订阅

MedSci主页 / 所有栏目 / 麻醉疼痛指南

2022 ESAIC/ESRA指南：服用抗栓药物患者的局部麻醉

2022-01-02 欧洲麻醉和重症监护学会 Eur J Anaesthesiol

局部麻醉

2022年1月，欧洲麻醉和重症监护学会(ESAIC)联合欧洲局部麻醉和疼痛治疗学会(ESRA)发布了服用抗栓药物患者的局部麻醉指南。

中文标题：

2022 ESAIC/ESRA指南：服用抗栓药物患者的局部麻醉

英文标题：

Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines

发布机构：

欧洲麻醉和重症监护学会

发布日期：

2022-01-02

简要介绍：

2022年1月，欧洲麻醉和重症监护学会(ESAIC)联合欧洲局部麻醉和疼痛治疗学会(ESRA)发布了服用抗栓药物患者的局部麻醉指南。出血是神经轴和周围神经阻滞后的潜在并发症，服用抗血小板药物和抗凝药物的患者相关风险增加。本文主要针对服用抗栓药物患者的局部麻醉提供指导建议，以降低与局部麻醉和镇痛相关的抗血小板药物诱发血肿形成的风险。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 ESAIC／ESRA指南：服用抗栓药物患者的局部麻醉.pdf)] GetToolGuiderByIdResponse(projectId=1, id=286d31c002311669, title=2022 ESAIC/ESRA指南：服用抗栓药物患者的局部麻醉, enTitle=Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines, guiderFrom=Eur J Anaesthesiol, authorId=0, author=, summary=2022年1月，欧洲麻醉和重症监护学会(ESAIC)联合欧洲局部麻醉和疼痛治疗学会(ESRA)发布了服用抗栓药物患者的局部麻醉指南。, cover=https://img.medsci.cn/202215/1641361043674_1608702.jpg, journalId=0, articlesId=null, associationId=2271, associationName=欧洲麻醉和重症监护学会, associationIntro=欧洲麻醉和重症监护学会(ESAIC,European Society of Anaesthesiology and Intensive Care), copyright=0, guiderPublishedTime=Sun Jan 02 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年1月，欧洲麻醉和重症监护学会(ESAIC)联合欧洲局部麻醉和疼痛治疗学会(ESRA)发布了服用抗栓药物患者的局部麻醉指南。出血是神经轴和周围神经阻滞后的潜在并发症，服用抗血小板药物和抗凝药物的患者相关风险增加。本文主要针对服用抗栓药物患者的局部麻醉提供指导建议，以降低与局部麻醉和镇痛相关的抗血小板药物诱发血肿形成的风险。</span></p>, tagList=[TagDto(tagId=8411, tagName=局部麻醉)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8411, guiderKeyword=局部麻醉, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5470, appHits=98, showAppHits=0, pcHits=385, showPcHits=5372, likes=0, shares=8, comments=4, approvalStatus=1, publishedTime=Wed Jan 05 13:32:09 CST 2022, publishedTimeString=2022-01-02, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Jan 05 13:34:51 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 19:50:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ESAIC／ESRA指南：服用抗栓药物患者的局部麻醉.pdf)])
2022 ESAIC／ESRA指南：服用抗栓药物患者的局部麻醉.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197757, encodeId=3495119e757a5, content=最好有中文对照就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Sun Feb 27 15:16:40 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182882, encodeId=e469118288260, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:49:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181147, encodeId=88d6118114e07, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:08 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-02-27 悠游小鱼儿

    最好有中文对照就好了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197757, encodeId=3495119e757a5, content=最好有中文对照就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Sun Feb 27 15:16:40 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182882, encodeId=e469118288260, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:49:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181147, encodeId=88d6118114e07, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:08 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-10 liuyan8586

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197757, encodeId=3495119e757a5, content=最好有中文对照就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210117/dcf1ab8de0ad4fdebbb81da7b96c0a66/7cafcf46965e4df0a1da0b5e959abfaf.jpg, createdBy=25282541486, createdName=悠游小鱼儿, createdTime=Sun Feb 27 15:16:40 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182882, encodeId=e469118288260, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b9a1569376, createdName=liuyan8586, createdTime=Mon Jan 10 16:49:32 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181147, encodeId=88d6118114e07, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Thu Jan 06 07:25:08 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-06 微探

    学习学习

    0

相关指南

2018 ASRA循证指南：接受抗栓或溶栓治疗患者进行区域阻滞麻醉（第4版）

美国区域麻醉和疼痛医学学会(ASRA,American Society of Regional Anesthesia and Pain Medicine) · 2018-03-20

拓展阅读

2018 ASRA循证指南：接受抗栓或溶栓治疗患者进行区域阻滞麻醉（第4版）

美国区域麻醉和疼痛医学学会(ASRA,American Society of Regional Anesthesia and Pain Medicine) · 2018-03-20